1. Home
  2. XTNT vs LSE Comparison

XTNT vs LSE Comparison

Compare XTNT & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XTNT
  • LSE
  • Stock Information
  • Founded
  • XTNT N/A
  • LSE 2007
  • Country
  • XTNT United States
  • LSE China
  • Employees
  • XTNT N/A
  • LSE N/A
  • Industry
  • XTNT Biotechnology: Biological Products (No Diagnostic Substances)
  • LSE Metal Fabrications
  • Sector
  • XTNT Health Care
  • LSE Industrials
  • Exchange
  • XTNT Nasdaq
  • LSE Nasdaq
  • Market Cap
  • XTNT 89.8M
  • LSE 91.8M
  • IPO Year
  • XTNT N/A
  • LSE 2024
  • Fundamental
  • Price
  • XTNT $0.68
  • LSE $5.21
  • Analyst Decision
  • XTNT
  • LSE
  • Analyst Count
  • XTNT 0
  • LSE 0
  • Target Price
  • XTNT N/A
  • LSE N/A
  • AVG Volume (30 Days)
  • XTNT 104.0K
  • LSE 4.9K
  • Earning Date
  • XTNT 11-11-2025
  • LSE 05-08-2013
  • Dividend Yield
  • XTNT N/A
  • LSE N/A
  • EPS Growth
  • XTNT N/A
  • LSE N/A
  • EPS
  • XTNT N/A
  • LSE 0.14
  • Revenue
  • XTNT $127,766,000.00
  • LSE $57,385,142.00
  • Revenue This Year
  • XTNT $13.03
  • LSE N/A
  • Revenue Next Year
  • XTNT N/A
  • LSE N/A
  • P/E Ratio
  • XTNT N/A
  • LSE $37.24
  • Revenue Growth
  • XTNT 15.16
  • LSE N/A
  • 52 Week Low
  • XTNT $0.33
  • LSE $3.76
  • 52 Week High
  • XTNT $0.78
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • XTNT 58.12
  • LSE 47.69
  • Support Level
  • XTNT $0.62
  • LSE $5.11
  • Resistance Level
  • XTNT $0.67
  • LSE $5.34
  • Average True Range (ATR)
  • XTNT 0.04
  • LSE 0.21
  • MACD
  • XTNT 0.00
  • LSE -0.00
  • Stochastic Oscillator
  • XTNT 79.83
  • LSE 35.63

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: